Correction: Recent advances in potential drug nanocarriers for CNS disorders: a review
Tenpattinam Shanmugam Saraswathi1, Mohan Mothilal2, Sarad Pawar Naik Bukke3
1Department of Pharmaceutics, St. Peters Pharmacy College and Research Institute, St. Peters Institute of Higher Education and Research, Krishnagiri District, Hosur, 635130, Tamil Nadu, India.
No abstract available in PubMed .
More Related Videos
11:53Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Distance Corrections
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
